Literature DB >> 8104463

The spectrum of beta-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy.

C Bennani1, R Tamouza, F Rouabhi, M Benabadji, M Malou, J Elion, D Labie, C Beldjord.   

Abstract

We report here on the final results of an epidemiological survey involving 177 beta-thalassaemic chromosomes in Algeria. Four common mutations account for 86% of the chromosomes, the other ones carrying nine other rare mutations. Combination of these results with those of other smaller regional epidemiological studies indicates the existence of still a wider range of mutations. The nature and frequencies of these mutations, their linkage with RFLP-haplotypes, agree well with the history of the region. Knowledge of this spectrum of mutations enables the design of a diagnosis strategy that takes into account the local economical constraints.

Entities:  

Mesh:

Year:  1993        PMID: 8104463     DOI: 10.1111/j.1365-2141.1993.tb03075.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  On the diversity of beta-globin mutations, a reflection of recent historic events in Israel.

Authors:  D Labie; J Elion; C Beldjord
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

2.  The great heterogeneity of thalassemia molecular defects in Sicily.

Authors:  A Giambona; P Lo Gioco; M Marino; I Abate; R Di Marzo; M Renda; F Di Trapani; F Messana; S Siciliano; P Rigano
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

3.  The Spectrum of beta-Thalassemia Mutations in the Arab Populations.

Authors:  Laila Zahed
Journal:  J Biomed Biotechnol       Date:  2001

4.  β-Thalassemia pathogenic variants in a cohort of children from the East African coast.

Authors:  Alexander W Macharia; George Mochamah; Sophie Uyoga; Carolyne M Ndila; Gideon Nyutu; Metrine Tendwa; Emily Nyatichi; Johnstone Makale; Russell E Ware; Thomas N Williams
Journal:  Mol Genet Genomic Med       Date:  2020-05-11       Impact factor: 2.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.